AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+11.67%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$9.22B
AUM Growth
+$331M
(+3.7%)
Cap. Flow
-$367M
Cap. Flow
% of AUM
-3.98%
Top 10 Holdings %
Top 10 Hldgs %
56.36%
Holding
1,043
New
155
Increased
182
Reduced
486
Closed
210
Top Buys
| 1 |
Hess Midstream
HESM
|
+$148M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$106M |
| 3 |
CEQP
Crestwood Equity Partners LP
CEQP
|
+$99.9M |
| 4 |
MPLX
MPLX
|
+$76.6M |
| 5 |
Energy Transfer Partners
ET
|
+$70.9M |
Top Sells
| 1 |
Western Midstream Partners
WES
|
+$541M |
| 2 |
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
|
+$338M |
| 3 |
Williams Companies
WMB
|
+$39.2M |
| 4 |
Exxon Mobil
XOM
|
+$31.4M |
| 5 |
Verizon
VZ
|
+$24.2M |
Sector Composition
| 1 | Energy | 65.72% |
| 2 | Technology | 5.09% |
| 3 | Consumer Discretionary | 3.8% |
| 4 | Healthcare | 3.45% |
| 5 | Industrials | 3.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPHA
776
Innate Pharma
IPHA
$188M
| $282K | ﹤0.01% |
83,966
-9,752
| -10% | -$32.8K |
|
777
IQVIA
IQV
$32.1B
| $275K | ﹤0.01% |
1,190
-60
| -5% | -$13.9K |
|
|
LGVN
778
Longeveron
LGVN
$17.3M
| $271K | ﹤0.01% |
1,966
-246
| -11% | -$33.9K |
|
|
ALPN
779
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $269K | ﹤0.01% |
30,030
-3,785
| -11% | -$33.9K |
|
780
Alphabet (Google) Class C
GOOG
$2.86T
| $268K | ﹤0.01% |
1,920
-540
| -22% | -$75.4K |
|
781
ITT
ITT
$13.3B
| $267K | ﹤0.01% |
3,556
+150
| +4% | +$11.3K |
|
782
SPS Commerce
SPSC
$4.18B
| $266K | ﹤0.01% |
2,030
-345
| -15% | -$45.2K |
|
783
Aldeyra Therapeutics
ALDX
$343M
| $265K | ﹤0.01% |
59,706
-7,517
| -11% | -$33.4K |
|
784
Nike
NKE
$108B
| $263K | ﹤0.01% |
1,956
-2,947
| -60% | -$396K |
|
785
VistaGen Therapeutics
VTGN
$109M
| $263K | ﹤0.01% |
7,075
-629
| -8% | -$23.4K |
|
786
Travelers Companies
TRV
$61.7B
| $257K | ﹤0.01% |
1,406
-441
| -24% | -$80.6K |
|
|
787
Williams Companies
WMB
$70.5B
| $254K | ﹤0.01% |
7,591
-1,171,193
| -99% | -$39.2M |
|
788
Clene
CLNN
$65.1M
| $252K | ﹤0.01% |
3,202
-397
| -11% | -$31.2K |
|
789
Altimmune
ALT
$328M
| $249K | ﹤0.01% |
40,836
-5,148
| -11% | -$31.4K |
|
790
Uber
UBER
$196B
| $249K | ﹤0.01% |
+6,984
| New | +$249K |
|
|
IMMP
791
Immutep
IMMP
$242M
| $244K | ﹤0.01% |
89,102
-13,222
| -13% | -$36.2K |
|
792
Viking Therapeutics
VKTX
$2.83B
| $242K | ﹤0.01% |
80,540
-9,999
| -11% | -$30K |
|
793
Comcast
CMCSA
$125B
| $230K | ﹤0.01% |
4,903
-1,521
| -24% | -$71.4K |
|
794
Analog Devices
ADI
$122B
| $224K | ﹤0.01% |
1,356
-2,559
| -65% | -$423K |
|
795
Douglas Elliman
DOUG
$244M
| $221K | ﹤0.01% |
31,792
-4,021
| -11% | -$28K |
|
796
Amdocs
DOX
$9.4B
| $216K | ﹤0.01% |
2,631
-819
| -24% | -$67.2K |
|
797
Lennar Class A
LEN
$35.6B
| $216K | ﹤0.01% |
2,744
-330
| -11% | -$26K |
|
798
Kimco Realty
KIM
$15.2B
| $213K | ﹤0.01% |
8,616
-2,673
| -24% | -$66.1K |
|
799
Tyler Technologies
TYL
$24.1B
| $209K | ﹤0.01% |
470
-190
| -29% | -$84.5K |
|
800
Middleby
MIDD
$6.99B
| $207K | ﹤0.01% |
1,262
+175
| +16% | +$28.7K |
|